标题: | 中华医学会肺癌临床诊疗指南(2020版) |
title: | Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2020 edition) |
版本: | 更新版 |
version: | Updated |
分类: | 标准指南 |
classification: | Standard guideline |
领域: | 诊疗 |
field: | Diagnosis and Treatment |
国家和地区: | 中国 |
Country and region: | China |
指南使用者: | 各级临床医务人员 |
Guide users: | Health care workers |
证据分级方法: | Category 1 Based upon high-level evidence, there is a uniform consensus of the Expert Committee that the intervention is appropriate. Category 2A Based upon lower-level evidence, there is a uniform consensus of the Expert Committee that the intervention is appropriate. Category 2B Based upon lower-level evidence, there is a consensus of the Expert Committee that the intervention is appropriate. Category 3 Based upon any level of evidence, there is a major disagreement of the Expert Committee that the intervention is appropriate. |
Evidence grading method: | |
制定单位: | 中华医学会肺癌临床诊疗指南(2020版)专家委员会 |
Formulating unit: | the Expert Committee of Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2020 edition) |
注册时间: | 2021-03-23 |
Registration time: | |
注册编号: | IPGRP-2021CN058 |
Registration number: | |
指南制订的目的: | 为进一步规范我国肺癌防治措施、提高肺癌的诊疗水平、改善患者的预后,并给各级临床医务人员提供肺癌筛查、诊断、病理、治疗和随访等方面的推荐意见。 |
Purpose of the guideline: | For standardizing the diagnosis and management, improving the prognosis of lung cancer, and providing authoritative guidance in screening, diagnosis, pathological typing, treatment, and follow-up of lung cancer for health workers. |
最新注册